Two sources of megakaryocytes were used for these experiments: Cord blood-derived CD34 + 23 cells and a megakaryoblastic cell line (Meg-01). Cord blood CD34 + stem cells were purchased 24 and cultured in StemSpanII media with the megakaryocyte supplemental cytokines, according to 25 the culture and differentiation protocols from Stemcell Technologies (Stemcell Technologies, 26 Vancouver, BC, Canada). TheMeg-01 cells was purchased and cultured in RPMI with 10% FBS, 27 according to the standard culture protocols from ATCC (American Type Culture Collection, 28
Manassas, VA). All cells were incubated in sterile conditions at 37 o C. 29 30
Platelet and white blood cell isolation 31
For the evaluation of blood cells for the presence of histones, blood was acquired from Research 32 Blood Components, LLC (Boston, MA). As a positive control for histone staining, neutrophil 33 isolation was performed. For this, blood was collected in ACD BD Vacutainer tubes (Becton 34 Dickinson, Franklin Lakes, NJ, USA). Neutrophils were isolated from whole blood using a 35 negative-selection protocol. In brief, neutrophils were isolated using a density gradient with 36
HetaSep (Stemcell Technologies) and then purified with EasySep Human Neutrophil Kit 37 (Stemcell Technologies), following the manufacturer's protocol. Neutrophil purity was assessed 38 to be >98%, and cell count was performed using a hemocytometer. Neutrophils were 39 subsequently resuspended in IMDM with 20% FBS (Thermo Fisher Scientific). . Platelets were 40 prepared from blood collected into 2.9 ml 3.2% trisodium citrate Vacutainer tubes (Sarstedt, 41 N¨umbrecht, Germany). Platelet-rich plasma (PRP) was first prepared by centrifugation of the 42 whole blood at 210 g, 22°C, for 20 min. The PRP supernatant was gently pipetted into a new 43 tube and 20% volume ACD solution was added (Boston Bioproducts, Ashland, MA, USA) and 44 then centrifuged at 1900 g, 22°C, for 10 min. The platelet-poor plasma (PPP) was removed, 45 leaving a platelet pellet which was resuspended in Hepes-Tyrode buffer with 20% volume ACD 46 solution (Boston BioProducts). 47
48

Immunofluorescence Imaging 49
Both Meg-01 and cord-blood derived MKs (CB MKs) were fixed and stained for the evaluation 50 of cellular histone localization using immunofluorescence staining. Platelet pellets were prepared 51 as described in the 'Blood cell sample preparation' section above. CB MKs, at day 14 of 52 differentiation, and platelet pellets were fixed with 4% paraformaldehyde for 30 minutes and 53 then concentrated onto a poly-lysine coated slide using the Cytospin 4 cytocentrifuge (Thermo 54 Fisher Scientific), for 5 minutes at 1250 rpm, rinsed once with Deionized (DI) water and stored 55 at -80 o C until staining and evaluation. For the LPS-stimulation of Meg-01 cells, Meg-01 cells 56 were co-incubated with various concentrations (30 pg/mL and 3 ug/mL) of E. coli 57 lipopolysaccharide (LPS) (O111:B4; Sigma Aldrich, St Louis, MO), for 60 minutes at 37 o C on 58 poly-lysine coated slides (Sigma Aldrich, St Louis, MO, USA) and then fixed with 4% 59 paraformaldehyde (Santa Cruz Biotechnology, Dallas, TX, USA). The slides were then rinsed 60 with DI water and stored at -80 o C until staining and evaluation. For staining, the slides were 61 thawed at room temperature and blocked with 5% donkey serum (Jackson Immunoresearch) for 62 2 hours. The slides were rinsed three times with PBS and then treated with various combinations 63 of the following primary antibodies for two hours at room temperature: rat anti-Histone H3 64 (phospho S28) antibody (HTA28; Abcam, Cambridge, MA, USA) at 1:500, rabbit anti-Histone H4 (39270; Active Motif, Carlsbad, Ca, USA), rabbit anti-Histone H2A.X (Active Motif), rabbit 66 anti-Histone 3 (ab1791; Abcam, Cambridge, MA, USA), and mouse anti-Histone 3 (96C10; Cell 67
Signaling Technology, Danvers, MA, USA) at 1:200. The slides were then rinsed three times 68 with PBS and incubated with various combinations of the following secondary antibodies: mouse 69 anti-human CD41 (GPIIb) 488 or 647 (Biolegend, San Diego, Ca, USA) at 1:250, donkey anti-70 rabbit 488, donkey anti-rat 647, and donkey anti-mouse 568 (Life Technologies) at 1:500 for 30 71 minutes at room temperature. Slides were then rinsed three times with PBS and covered with 72
Vectashield antifade mounting medium with DAPI (Vector Labs, Burlingame, Ca, USA). The 73 cells were then imaged with one of two fluorescent microscopes: Life Technologies EVOS FL 74 (Thermo Fisher Scientific) or Nikon Eclipse 90i microscope (Nikon Instruments Inc., Melville, 75 NY). 76 77
Histone-2B BacMam transfection of Meg-01 cells 78
Meg-01 cells were transfected with GFP-Histone 2B (H2B) for localization of intracellular 79 histone. Meg-01 cells were transfected with CellLight Histone 2B-GFP (BacMam 2.0, 80
ThermoFisher Scientific) at 30 uL/mL for 48-72 hours at 37 o C. Cell were then labeled with 81 MitoSox Red mitochondrial superoxide indicator (ThermoFisher Scientific) at 1:1000 Hoechst at 82 1:2000 for 30 minutes. Cells were pelleted at 1,900 x g for 10 minutes and rinsed twice with 83 PBS. Cells were then concentrated onto a poly-lysine coated slide using the Cytospin 4 84 cytocentrifuge (Thermo Fisher Scientific), for 5 minutes at 1250 rpm. Slides were rinsed with DI 85 water, cover slipped, and imaged on an EVOS fluorescent microscope. 86 87
Histone purification 88
Histones were extracted from both isolated platelet pellets and Meg-01 cells for histone 89 quantification. For sample preparation, venous whole blood was collected in acid citrate dextrose 90 (ACD) tubes (Research Blood Components LLC, Boston, MA, USA). Platelet pellets were 91 isolated as described in the section above, 'Blood cell sample preparation'. Meg-01 cells were 92 pelleted down at 1900 x g for 10 minutes. For histone purification the Active Motif Histone 93
Purification Mini Kit (Active Motif, Carlsbad, CA) was utilized per the manufacturer's 94 instructions. Briefly, platelet and cell pellets were washed twice with hepes-tyrode buffer and 95 20% acid citrate dextrose buffer (Boston BioProducts, Boston, MA, USA). Pellets were then re-96 suspended in ice-cold Extraction Buffer. Samples were homogenized in the Extraction Buffer for 97 30 minutes and then left overnight at 4 o C. The samples were then spun at maximum speed 98 (18,000 x g) in a microfuge for 5 minutes at 4 o C. The supernatant, containing the crude histones, 99 was then transferred to a new tube and neutralized with 5X Neutralization Buffer to a pH of 8. 100
One aliquot of crude histones was saved for downstream analysis at -80 o C. Spin columns 101 provided by the kit were then equilibrated and the crude histones along with the Elution Buffer 102 were run through the columns at 500 x g for 3 minutes. One aliquot of the eluted histones was 103 saved for downstream analysis at -80 o C. Histones were then precipitated with perchloric acid. 104
Briefly, histones were precipitated overnight at 4 o C with 4% perchloric acid. The histones were 105 then spun down at maximum speed for 1 hour at 4 o C. The pellet was washed with 1 mL cold 4% 106 perchloric acid, followed by two washes in ice cold acetone with 0.2% HCl, and then twice in ice 107 cold acetone. The resulting pellet was air dried for 10 minutes and then re-suspended in sterile 108 water. All histones and aliquots were stored at - . Table 2) . Briefly, the samples were co-123 incubated with multiple magnetic beads, which were conjugated to antibodies targeted to specific 124 H3 PTSMs, on a shaker plate for 2 hours. The beads were then washed 3 times, incubated with 125 biotinylated anti-H3 antibodies on a shaker plate for 30 minutes, washed 3 times and then 126 incubated with streptavidin-phycoerythrin for 30 minutes, followed by a final set of 127 washes. Samples were read by using a Flexmap 3D (Luminex Corp., Austin, TX). The standard 128 curve was generated by using 5-parametric-curve fitting with platform-specific software 129 (xPONENT Software Solutions, Luminex). Samples were run in duplicate on each plate for 130 quality control. 131 132 LLC, Boston, MA), age and sex not known. Platelet pellets were isolated as described in the 167 'Platelet isolation' section from venous blood collected in vacutainer EDTA tubes and then 168 frozen at -80 o C until analyzed. Flow cytometry was performed as described below, in the 'Flow 169 cytometry' section. For the assessment of histone expression, platelet pellets were either treated 170 with 4% paraformaldehyde fixation with 0.1% Triton™ X-100 or with 4% paraformaldehyde 171 alone. The pellets were washed prior to staining and evaluating. To assess for the effect of 172 freeze-thawing on the patient platelet pellets, one set of control samples (n=5) was divided into 173 two aliquots and one was run "fresh" without freeze-thawing and the other was freeze-thawed. 174
Transmission electron microscopy and immune-gold labeling
Both samples were pre-treated with 4% paraformaldehyde fixation with 0.1% Triton™ X-100 175 permeabilization. One set of samples was then frozen at -80 o C. For the sepsis sample evaluation, 176 platelet pellets were pre-treated with 4% paraformaldehyde fixation with 0.1% Triton™ X-100 177 permeabilization, pellets were stored at -80 o C until ready to evaluate. They were then thawed and washed prior to staining and evaluation. Samples were evaluated as described in the section 179 below, 'Flow cytometry'. 180 181
Flow cytometry 182
Flow cytometry was performed to evaluate cells and platelets for histone expression. Cultured 183
Meg-01 cells, isolated platelets, and whole blood were fixed with 4% paraformaldehyde with or 184 without 0.1% Triton™ X-100 detergent (Sigma-Aldrich) for permeabilization for a total of 10 185 minutes. For the whole blood samples, platelets were isolated as described above in the 'Platelet 186
Isolation' section prior to fixing. After fixing, samples were then pelleted down at 1,900 x g for 187 
